However, the outcome of patients with triple‐negative breast cancer was not correlated with FAM189A2 expression (unpublished observation), indicating that FAM189A2 primarily impacts the biology of the luminal A‐ and HER2‐enriched subtypes of breast cancer. Here, ERBB2 is linked to breast carcinoma.